Lenos, Kristiaan J. http://orcid.org/0000-0003-1165-8732
Bach, Sander
Ferreira Moreno, Leandro
ten Hoorn, Sanne
Sluiter, Nina R.
Bootsma, Sanne
Vieira Braga, Felipe A.
Nijman, Lisanne E.
van den Bosch, Tom http://orcid.org/0000-0002-5266-8446
Miedema, Daniel M.
van Dijk, Erik http://orcid.org/0000-0002-6272-2039
Ylstra, Bauke http://orcid.org/0000-0001-9479-3010
Kulicke, Ruth
Davis, Fred P.
Stransky, Nicolas
Smolen, Gromoslaw A. http://orcid.org/0000-0003-0136-4685
Coebergh van den Braak, Robert R. J. http://orcid.org/0000-0001-9310-6629
IJzermans, Jan N. M. http://orcid.org/0000-0003-3558-1039
Martens, John W. M. http://orcid.org/0000-0002-3428-3366
Hallam, Sally
Beggs, Andrew D. http://orcid.org/0000-0003-0784-2967
Kops, Geert J. P. L. http://orcid.org/0000-0003-3555-5295
Lansu, Nico
Bastiaenen, Vivian P.
Klaver, Charlotte E. L.
Lecca, Maria C.
El Makrini, Khalid
Elbers, Clara C.
Dings, Mark P. G. http://orcid.org/0000-0001-8509-0006
van Noesel, Carel J. M.
Kranenburg, Onno http://orcid.org/0000-0002-2112-4390
Medema, Jan Paul
Koster, Jan http://orcid.org/0000-0002-0890-7585
Koens, Lianne
Punt, Cornelis J. A.
Tanis, Pieter J. http://orcid.org/0000-0002-3146-3310
de Hingh, Ignace H.
Bijlsma, Maarten F.
Tuynman, Jurriaan B. http://orcid.org/0000-0001-5952-8000
Vermeulen, Louis http://orcid.org/0000-0002-6066-789X
Funding for this research was provided by:
KWF Kankerbestrijding (13435, 10529)
ZonMw (Vidi 016.156.308)
This work is supported by the Academic Medical Center (Amsterdam), The New York Stem Cell Foundation, L.V. is a New York Stem Cell Foundation – Robertson Investigator.
Article History
Received: 16 February 2022
Accepted: 21 July 2022
First Online: 4 August 2022
Competing interests
: L.V. received consultancy fees from Bayer, MSD, Genentech, Servier and Pierre Fabre, but these had no relation to the content of this publication. I.H.d.H. received research funding (paid to institute) from Roche and RandD for unrelated research. R.K., F.P.D., N.S., and G.A.S. are employees of and have ownership interest in Celsius Therapeutics. All other authors declare no conflict of interest in the context of this publication.